Early Diagnostic Value Of Serum AFP, CA125, TBA Alone And Combined Detection For Hepatocellular Carcinoma

Objective: To study and analyze the sensitivity of TBA, CA125 and AFP in the diagnosis of primary liver cancer, and to provide a new method for the early diagnosis of primary liver cancer. Methods: Have been collected from January 2010 to September 2015 the clinical data of Qinghai University Hospital with 60 cases of HBV-related liver cancer patients with primary, 40 cases of Posthepatitic cirrhosis and 25 patients with the same period a year physical examination. Statistics in the three groups, respectively, the expression of serum markers AFP, CA125, TBA. Separate and joint diagnoses were calculated sensitivity, specificity, and analyzed whether the difference was statistically significant. Results: This study showed that there were no significant differences in age and sex between the three groups. The sensitivity of AFP, CA125 and TBA combined detection in early diagnosis of primary liver cancer was higher than that of any single item. Conclusion: For primary hepatocellular carcinoma, the combined detection of AFP, CA125 and TBA is superior to detect individual indicators.